Patent clearance penalises inventors
TRANSKRIPT - Patent clearance penalises inventors and destroys the scope for venture capital: The COVID-19 pandemic may have peaked, but the debate…
The Life Sciences Acceleration Alliance e.V. (LSAA) is a coalition of venture capitalists, corporate leaders, and subject matter experts dedicated to strengthening life sciences innovation and development in the EU seeking to ensure that policy in Europe evolves towards medical discovery, commercialisation and the benefit to patients.
There is an opportunity for proactive policies that could better commercialise innovation and yield economic and health benefits
Here you can change your privacy preferences.